Clinical Trials on Cornea Ectasia in Australia

Total 555 results

Occyo GmbH
University Clinic for Ophthalmology and Optometry- Salzburg

Completed

CDL Validation Study

Limbal Stem-cell Deficiency | Cornea Disease | Eyes Dry Chronic | Chronic Conjunctivitis of Both Eyes | Eye Lesion | Eye Disease; Cataract | Eyes Dry Feeling of | Cornea Inflamed | Cornea; Injury, Abrasion | Cornea Infection

Austria
Kirby Institute

Not yet recruiting

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

Hepatitis C

Australia
Medical University of Vienna

Completed

High-resolution Imaging of Corneal Lesions With Optical Coherence Tomography (OCT) - A Pilot Study

Corneal Infiltrates | Corneal Abrasions

Austria
Medical University of Vienna

Unknown

Agreement and Accuracy of Different Devices for Biometry Measurements in Patients With Cataract (Comparison)

Cataract | Surgery | Cornea

Austria
Medical University of Vienna

Completed

Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study

Keratoconus | Corneal Neovascularisation

Austria
Medical University of Vienna

Recruiting

Correlation Between In-vivo Anatomy of Corneal Dystrophies as Assessed by High- Resolution Optical Coherence Tomography (OCT) Measurement and Histological Examination

Corneal Dystrophy

Austria
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer... and other collaborators

Completed

Can Resistance Enhance Selection of Treatment? (CREST)

HIV Infection

Australia
Medical University of Vienna

Completed

Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT

Fuchs' Endothelial Dystrophy

Austria
Klinikum Klagenfurt am Wörthersee
University of Klagenfurt

Recruiting

Influence of Pupillary Behavior During Eye Surgery on Morphological and Functional Outcome

Cataract | Corneal Disease | Vitreous Disorder

Austria
Medical University of Vienna

Completed

Optical Biometry and Spherical Aberration in Ametropic and Emmetropic Eyes

Refractive Errors | Corneal Wavefront Aberration | Axial Length, Eye

Austria
Vienna Institute for Research in Ocular Surgery

Terminated

Effect of Chitosan-N-acetylcysteine on Subjective Pain Sensation in Corneal Abrasion

Eye Diseases

Austria
Paracelsus Medical University

Completed

Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation

Glaucoma | Endothelial Cell Loss, Corneal

Austria
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP

Malaria

Australia
Johannes Kepler University of Linz

Completed

Evaluation of the German Version of a Validated Keratoconus Questionaire (KORQ)

Keratoconus, Unspecified, Bilateral

Austria
Alcon Research

Completed

Evaluation of Comfort in Subjects With Moderate Dry Eye Disease

Dry Eye

Australia
Merck Sharp & Dohme LLC

Recruiting

A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)

Malaria

Australia
Medical University of Vienna

Completed

Accelerated Corneal Cross-linking With Different Riboflavin Solutions

Keratoconus

Austria
Vienna Institute for Research in Ocular Surgery

Unknown

Epithelial Thickness Map

Keratoconus

Austria
Medical University of Vienna

Completed

Effect of CACICOL20 on Corneal Epithelial Healing After Cross-linking in Patients With Keratoconus

Keratoconus

Austria
Medical University of Vienna

Completed

Distinguishing Healthy and Keratoconic Eyes Using Ultrahigh-Resolution OCT

Keratoconus

Austria
Gerald Schmidinger

Completed

Agreement and Accuracy of Different Devices Corneal Measurements

Keratoconus

Austria
Serum Institute of India Pvt. Ltd.
PPD

Completed

Safety Study of Dengushield in Healthy Adults

Dengue | Phase 1

Australia
Kiora Pharmaceuticals, Inc.

Terminated

A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune Disease

Dry Eye Disease

Australia
National Institute of Allergy and Infectious Diseases...

Completed

Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A

Malaria

Australia
Alcon Research

Completed

Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population

Corneal Astigmatism | Aphakia

Australia
The University of New South Wales

Completed

The Effects of Dietary Supplementation With Omega-3 Fatty Acids on Symptoms of Dry Eye

Dry Eye

Australia
Johannes Kepler University of Linz

Completed

Keratoconus Detection Using MS39 and Pentacam (KKMS39Penta)

Keratoconus

Austria
Serum Institute of India Pvt. Ltd.
PPD Australia Pty Ltd

Completed

A Phase 1 Safety Study of Dengusiil in Healthy Adults

Prevention of Dengue Fever

Australia
sigma-tau i.f.r. S.p.A.
CPR Pharma Services Pty Ltd, Australia

Completed

Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers

Malaria, Falciparum

Australia
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Drug Drug Interaction Study for EYP001 With Entecavir

Hepatitis B, Chronic

Australia
Fremantle Hospital and Health Service

Completed

In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia

Hepatitis C

Australia
Johannes Kepler University of Linz

Recruiting

Validation of Interleukins and Other Cytokines Together With OCT Imaging for Rapid Infectious Keratitis Assessment (VICTORIA)

Keratitis Bacterial | Keratitis Fungal

Austria
Kowa Research Institute, Inc.

Completed

Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis

Fuchs' Endothelial Corneal Dystrophy

United States, Australia, Germany, Spain, Denmark
Medicines for Malaria Venture
Nucleus Network Ltd; Southern Star Research Pty Ltd.

Completed

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; Queensland Institute...

Terminated

A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection (DSMOZ-2)

Malaria

Australia
Medicines for Malaria Venture
Nucleus Network Ltd; Southern Star Research Pty Ltd.

Completed

MMV533 Plasmodium Falciparum Volunteer Infection Study

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer... and other collaborators

Completed

Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent (OZGAM)

Malaria

Australia
Medicines for Malaria Venture
Nucleus Network Ltd; Southern Star Research Pty Ltd.

Completed

Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer... and other collaborators

Completed

Experimental Falciparum Transmission to Anopheles (EFITA)

Malaria

Australia
GlaxoSmithKline

Terminated

A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

Malaria

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited; Clinical Network Services (CNS) Pty Ltd; QIMR Berghofer...

Completed

A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (OZ/DSMCombo)

Malaria

Australia
Medicines for Malaria Venture
Queensland Institute of Medical Research

Completed

Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers

Malaria

Australia
Panoptes Pharma GmbH

Completed

A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers

Keratoconjunctivitis | Ocular Surface Disease

Austria
Vienna Institute for Research in Ocular Surgery

Completed

Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism

Cataract | Corneal Astigmatism

Austria
sigma-tau i.f.r. S.p.A.
CPR Pharma Services Pty Ltd, Australia

Completed

A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™

Malaria, Falciparum

Australia
Medicines for Malaria Venture
Q-Pharm Pty Limited

Terminated

MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants

Malaria, Falciparum

Australia
TetraLogic Pharmaceuticals

Terminated

Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B

Hepatitis B

Australia
Idorsia Pharmaceuticals Ltd.

Completed

Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects

Healthy Subjects

Australia

Clinical Trials on Cornea Ectasia in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations